DPT-IPV-Hib vaccine (Mitsubishi Tanabe Pharma)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameDPT-IPV-Hib vaccine (Mitsubishi Tanabe Pharma)
Drug Alias Name百日せき菌の防御抗原 ジフテリアトキソイド 破傷風トキソイド 不活化ポリオウイルス 1～3型（Ｓａｂｉｎ 株） インフルエンザ菌ｂ型 オリゴ糖－ＣＲＭ１９ ７結合体GobikMT-2355BK-1310
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[7] 
Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2023/03/27
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBikenMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesBiken
Inactive CompaniesMitsubishi Tanabe Pharma Corp
Active IndicationsPoliomyelitisTetanusDiphtheria +[5] 
Inactive IndicationsMeningitis, BacterialInfections

Other Information

ATC CodeN/A
Related LinksN/A